Hexahydropyridoisoqinolines as DPPIV inhibitors

Details for Australian Patent Application No. 2004251829 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Mattei, Patrizio; Kuhn, Bernd; Wessel, Hans Peter; Luebbers, Thomas; Boehringer, Markus; Narquizian, Robert

Agent Spruson & Ferguson

Pub. Number AU-B-2004251829

PCT Pub. Number WO2005/000846

Priority 03013405.0 20.06.03 EP

Filing date 11 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 17 December 2009

International Classifications

A61K 31/4745 (2006.01)

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000846 Priority application(s): WO2005/000846

17 December 2009 Application Accepted

  Published as AU-B-2004251829

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251830-Pyrido` 2, 1-a - isoquinoline derivatives as DPP-IV inhibitors

2004251827-Process for preparing acylsulfamoylbenzamides